CTI BioPharma Corp. (CTIC) Stock Rebounds Premarket Following FDA Accelerated Approval.
Maria Masood
March 1, 2022
CTI BioPharma Corp. (CTIC) a commercial-stage biotherapeutics company engaged in the purchase, manufacture, and marketing of innovative targeted therapeutics for blood cancer. The company’s one